Cannabinoids and Neuropsychiatric Disorders
Springer International Publishing
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
| Title |
Cannabinoids and Neuropsychiatric Disorders
|
|---|---|
| Published by |
Springer International Publishing, January 2021
|
| DOI | 10.1007/978-3-030-57369-0 |
| ISBNs |
978-3-03-057368-3, 978-3-03-057369-0
|
| Editors |
Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti |
X Demographics
The data shown below were collected from the profiles of 178 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 24 | 13% |
| United States | 22 | 12% |
| Colombia | 5 | 3% |
| Venezuela, Bolivarian Republic of | 4 | 2% |
| Germany | 3 | 2% |
| Peru | 3 | 2% |
| Poland | 2 | 1% |
| Chile | 2 | 1% |
| Ecuador | 2 | 1% |
| Other | 23 | 13% |
| Unknown | 88 | 49% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 158 | 89% |
| Scientists | 10 | 6% |
| Practitioners (doctors, other healthcare professionals) | 8 | 4% |
| Science communicators (journalists, bloggers, editors) | 2 | 1% |